PGM3 and pancreatic neoplasm: Upon increasing GEM doses, PGM3 and global protein O-GlcNAcylation levels are decreased in sensitive BxPC-3 pancreatic cancer cells but increased in PANC-1 and MIA PaCa-2 resistant ones (110).